CASI PHARMACEUTICALS, INC. Stock Repurchase Program, Authorized Amount
CASI PHARMACEUTICALS, INC. (CASIF) had Stock Repurchase Program, Authorized Amount of $10.00 million as of 2021-12-15, per its 20-F filed 2024-03-28.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramAuthorizedAmount1 · last filed 2024-03-28
- 2021-12-15: Stock Repurchase Program, Authorized Amount $10.00M.
| Period end | Stock Repurchase Program, Authorized Amount |
|---|---|
| 2021-12-15 | $10.00M 20-F · filed 2024-03-28 |